Is Radium-223 general bone pain palliation?
No. It has a distinct specialist indication, assessment pathway and treatment course.
Specialist treatment assistance
Targeted alpha therapy assessment for selected prostate cancer patients with symptomatic bone-predominant disease.
SavoScan.com provides patient assistance and booking support. Treatment is delivered by the selected healthcare centre.
Radium-223 behaves similarly to calcium and targets areas of increased bone turnover, delivering short-range alpha radiation.
Selected patients with advanced prostate cancer and appropriate bone-dominant disease may be referred after specialist review.
The team reviews disease distribution, symptoms, blood counts, prior and current treatments, fracture risk and clinical goals.
Diagnostic imaging and radionuclide therapy are different services. The treating specialist decides which scans and reports are required.
Recent blood tests are required and medicine or bone-health plans may be reviewed. Follow the centre’s exact instructions.
Administration is commonly outpatient, subject to patient condition and centre protocol.
Diarrhoea, nausea, fatigue and blood-count suppression may occur. The team reviews marrow reserve, fracture risk and treatment combinations.
Blood counts and symptoms are checked during the course; oncology follow-up continues alongside treatment.
A linked scan is not automatically required for treatment. Follow the treating specialist’s advice.
Treatment-specific guidance
No. It has a distinct specialist indication, assessment pathway and treatment course.
Confirm the pricing basis. A planned course can involve multiple administrations.
Patient assistance
Share your contact preference. Our team can help identify confirmed centre options and request a clearly labelled estimate.
Suitability, preparation, administered activity, admission and follow-up are determined by the treating centre’s qualified specialists.